Global Healthcare Study on Atopic Dermatitis
Recruiting
Observational Study
Atopic Dermatitis (AD)
Atopic Dermatitis (Eczema)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 14 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 9,600 (estimated)
- Sponsor
- Julia Tatjana Maul · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The Global Healthcare Study on Atopic Dermatitis (GHSAD) is an international, multicenter observational study hosted by the University of Zurich (UZH) investigating healthcare access, treatment patterns, disease severity, and quality of life in patients with atopic dermatitis. The study collects standardized clinical data from routine medical records to identify disparities in healthcare delivery …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Signed General Consent Form, or equivalent document
* Confirmed diagnosis of Atopic Dermatitis
Exclusion Criteria:
* Inability to provide informed consent.
* Datasets with ambiguous or unclear diagnosis.
Contacts